Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase our technology at the Global Life Science Partnering & Investor Conference presented by BIOCOM California taking place February 27 – 29, 2024 in La Jolla, California. Immunophotonics is thrilled to take part in this exclusive global partnering forum that unites senior executives, CEO’s, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.

Lu Alleruzzo, CEO of Immunophotonics’ will be presenting on February 28th at 3:21 pm (PST) and see how Immunophotonics is advancing the novel concept of abscopalizing routine tumor destruction procedures. “Abscopalize It!™”